Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial

Dorsomedial prefrontal cortex (DMPFC) repetitive transcranial magnetic stimulation (rTMS) is a novel intervention for treatment-refractory depression (TRD). To date, many open-label case series and one randomized controlled trial of modest sample size have provided preliminary evidence that DMPFC-rTMS is an effective treatment for TRD. Here, we report the results of a large, double-blinded, sham-controlled trial of DMPFC-rTMS for TRD.

Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - October 30, 2019 Category: Neurology Authors: Katharine Dunlop, Jack Sheen, Laura Schulze, Peter Fettes, Farrokh Mansouri, Kfir Feffer, Daniel M. Blumberger, Zafiris J. Daskalakis, Sidney H. Kennedy, Peter Giacobbe, Blake Woodside, Jonathan Downar Source Type: research